Covered recipient · General Payments record
NITHIN KARAKALA
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$714.87
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $100.92 | 1 |
| Education | $25.47 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Relypsa, Inc. | $100.92 | 1 |
| Retrophin, Inc. | $25.47 | 6 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | $2.38 | 05/14/2024 | Education | Undisputed | 01/23/2026 | 1149959256 | CMS |
| Travere Therapeutics, Inc. | $0.37 | 05/14/2024 | Education | Undisputed | 01/23/2026 | 1149959281 | CMS |
| Travere Therapeutics, Inc. | $2.38 | 06/20/2024 | Education | Undisputed | 01/23/2026 | 1149959262 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 07/15/2024 | Education | Undisputed | 01/23/2026 | 1149959274 | CMS |
| Travere Therapeutics, Inc. | $0.37 | 08/06/2024 | Education | Undisputed | 01/23/2026 | 1149959250 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 10/01/2024 | Education | Undisputed | 01/23/2026 | 1149959268 | CMS |
| Vifor Pharma, Inc. | $100.92 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124059274 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.